Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316290 · ClinicalTrials.gov registry record · NA
Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT00316290: Completed NA study, sponsored by University of Maryland, College Park.
NCT00316290 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00316290, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of integrated parent training versus standard behavioral parent training in treating depression and stress in mothers of children with attention deficit hyperactivity disorder (ADHD).
Interventions
- BEHAVIORAL Behavioral Parent Training
- BEHAVIORAL Integrated Parent Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-12 |
| Phase | NA |
What the finished NCT00316290 record still lists
NCT00316290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral Parent Training is the first listed.
NCT00316290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00316290 about?
NCT00316290 is a clinical study titled "Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder". This study will determine the effectiveness of integrated parent training versus standard behavioral parent training in treating depression and stress in mothers of children with attention deficit hyperactivity disorder (ADHD).
What is the current status of trial NCT00316290?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2006-04. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00316290?
The interventions under investigation include: Behavioral Parent Training (BEHAVIORAL), Integrated Parent Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00316290?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00316290's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia